Market access webinar

Market access for biotechnology

An on-demand webinar for biotechnology manufacturers to discover the latest recommendations for market access success.

Fill in your details to watch this webinar

We respect your privacy. Cookie policy.

Highlights from a webinar hosted by

Learning aims

  • attain best practice for successfully navigating the value, access, and evidence process 
  • insights into the relevance and timing of a range of market access projects within biotechnology
  • obtain recommendations for assessing market access risks and opportunities based on pricing potential and evolving payer needs. 

Moderated by Dr Patti Peeples, President of



Steven has more than 15 years’ experience in sales, marketing, and market access roles in both consultancy and industry and has worked directly with payers and providers to facilitate market access of pharmaceutical products. 

He has a deep understanding of HTA/P&R processes and evidence requirements in major markets and has worked in numerous therapy areas, including oncology, hematology, gastroenterology, rheumatology, endocrinology, and rare diseases.  

Duration: 20 minutes.

Ideal viewing:

The discussion is essential viewing for biotechnology manufacturers that want to deliver faster patient access to innovative therapies.

Broadcast: 2021

“Thanks for the webinar. It was interesting to explore the case studies in depth and I found it useful to confirm our perspectives.”

Global Pricing and Reimbursement Director, leading pharmaceutical company 

“Very clear and concise presentation, thank you.” 

VP Market Access and Reimbursement, emerging biotech 

“Very informative session. The points covered are making me re-think the scope of possible work I’m considering.” 

HEOR Director, leading pharmaceutical company 

Market access for biotechnology